To test whether RIG-I responds to DNA damage, human lung carcinoma cells (A549) and breast adenocarcinoma cells (MDA-MB-231) were treated with IR, and the intracellular localization of RIG-I was examined. Here, RIGI is linked to breast adenocarcinoma.